Early research (Phase 1)Study completedNCT02529072What this trial is testingNivolumab With DC Vaccines for Recurrent Brain TumorsWho this might be right forMalignant GliomaAstrocytomaGlioblastoma Gary Archer Ph.D. 6
Early research (Phase 1)Looking for participantsNCT05366179What this trial is testingAutologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3TcWho this might be right forGlioblastoma Multiforme UNC Lineberger Comprehensive Cancer Center 36
Testing effectiveness (Phase 2)UnknownNCT00360945What this trial is testingCisplatin and Temozolomide in Treating Young Patients With Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Children's Cancer and Leukaemia Group 87
Early research (Phase 1)Study completedNCT00024557What this trial is testingHistologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma PatientsWho this might be right forMalignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more INSYS Therapeutics Inc 40
Large-scale testing (Phase 3)Looking for participantsNCT05902169What this trial is testingSonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMWho this might be right forGlioblastomaRecurrent GlioblastomaGBM CarThera 560
Early research (Phase 1)Study completedNCT00120939What this trial is testingStudy of Motexafin Gadolinium and Docetaxel for Advanced CancerWho this might be right forBreast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Ended earlyNCT01122901What this trial is testingGamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive GlioblastomaWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more National Cancer Institute (NCI) 47
Early research (Phase 1)Study completedNCT00002824What this trial is testingGene Therapy in Treating Patients With Primary Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Active Not RecruitingNCT02208362What this trial is testingGenetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant GliomaWho this might be right forRecurrent GlioblastomaRecurrent Malignant GliomaRecurrent WHO Grade II Glioma+5 more City of Hope Medical Center 65
Testing effectiveness (Phase 2)Study completedNCT00087061What this trial is testingGimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Jonsson Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT02149459What this trial is testingTreatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With RadiotherapyWho this might be right forBrain Neoplasms Sheba Medical Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT06264388What this trial is testingDB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic AstrocytomaWho this might be right forHigh Grade GliomaAnaplastic Astrocytoma Ashish Shah 33
Early research (Phase 1)Looking for participantsNCT07193628What this trial is testingB7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory GlioblastomaWho this might be right forRefractory GlioblastomaRecurrent Glioblastoma Second Affiliated Hospital, Zhejiang University, School of Medicine 14
Large-scale testing (Phase 3)WithdrawnNCT01830101What this trial is testingA Phase III Study of Re-Irradiation in Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma AHS Cancer Control Alberta
Large-scale testing (Phase 3)Study completedNCT02511405What this trial is testingA Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)Who this might be right forGlioblastoma Vascular Biogenics Ltd. operating as VBL Therapeutics 252
Testing effectiveness (Phase 2)Study completedNCT01301430What this trial is testingParvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.Who this might be right forGlioblastoma Multiforme Oryx GmbH & Co. KG 18
Testing effectiveness (Phase 2)Ended earlyNCT00479765What this trial is testing/ 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent GliomaWho this might be right forGlioblastoma MultiformeBrain Neoplasms Boston Scientific Corporation 4
Early research (Phase 1)Study completedNCT01158300What this trial is testingPTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System TumorsWho this might be right forBrain and Central Nervous System Tumors Pediatric Brain Tumor Consortium 28
Early research (Phase 1)Ended earlyNCT01269411What this trial is testingRO4929097 in Treating Patients With Recurrent Invasive GliomasWho this might be right forAdult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Giant Cell Glioblastoma+4 more National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT00093964What this trial is testingCilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)Who this might be right forGlioblastoma Multiforme EMD Serono 81